Stress sensitivity is increased in transgenic rats with low brain angiotensinogen

Journal of Endocrinology

Volumn 204, Issue 1, 2010, Pages 85-92

  Müller, Helge ^a   Kröger, Juliane ^a   Jöhren, Olaf ^a   Szymczak, Silke ^a   Bader, Michael ^b   Dominiak, Peter ^a   Raasch, Walter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; BRAIN PROTEIN; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN; MELANOCORTIN; MESSENGER RNA; NORADRENALIN; PROOPIOMELANOCORTIN; CORTICOTROPIN RELEASING FACTOR; MELANOCORTIN 2 RECEPTOR;

ADRENALIN BLOOD LEVEL; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; DRUG MECHANISM; FORCED SWIMMING TEST; HEART RATE; HEART WEIGHT; HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; STRESS; TISSUE LEVEL; TRANSGENIC RAT; ADRENAL GLAND; ANIMAL; BRAIN; GENETICS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; SWIMMING; UPREGULATION;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; BLOOD PRESSURE; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTOR, MELANOCORTIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; SWIMMING; UP-REGULATION;

EID: 73949085225     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0363     Document Type: Article

References (56)

1. Abou-Samra AB, Catt KJ & Aguilera G 1986 Involvement of protein kinase C in the regulation of adrenocorticotropin release from rat anterior pituitary cells. Endocrinology 118 212-217.
2. Aguilar F, Lo M, Claustrat B, Saez JM, Sassard J & Li JY 2004 Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats. Hypertension 43 87-93.
3. Aguilera G, Kiss A & Luo X 1995 Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. Journal of Neuroendocrinology 7 775-783.
4. Armando I, Carranza A, Nishimura Y, Hoe KL, Barontini M, Terron JA, Falcon-Neri A, Ito T, Juorio AV & Saavedra JM 2001 Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology 142 3880-3889.
5. Baltatu O, Silva JA Jr, Ganten D & BaderM2000 The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy. Hypertension 35 409-412.
6. Baltatu O, Janssen BJ, Bricca G, Plehm R, Monti J, Ganten D & Bader M 2001 Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen. Hypertension 37 408-413.
7. Blondet A, Doghman M, Penhoat A, Durand P, Begeot M & Naville D 2002 The human MC2-R gene expression: different aspects of its control. Endocrine Research 28 275-280.
8. Brasier AR & Li J 1996 Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27 465-475.
9. Burson JM, Aguilera G, Gross KW & Sigmund CD 1994 Differential expression of angiotensin receptor 1A and 1B in mouse. American Journal of Physiology 267 E260-E267.
10. Bustin SA 2002 Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of Molecular Endocrinology 29 23-39.
11. 1 receptors mediate chronic central nervous system AII hypertension in rats fed high sodium chloride diet from weaning. Journal of the Autonomic Nervous System 72 16-23.
12. Campos LA, Plehm R, Cipolla-Neto J, Bader M & Baltatu OC 2006 Altered circadian rhythm reentrainment to light phase shifts in rats with low levels of brain angiotensinogen. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 290 R1122-R1127.
13. Castren E & Saavedra JM 1988 Repeated stress increases the density of angiotensin II binding sites in rat paraventricular nucleus and subfornical organ. Endocrinology 122 370-372.
14. Chan O, Inouye K, Vranic M & Matthews SG 2002 Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 143 1761-1768.
15. Chan O, Inouye K, Riddell MC, Vranic M & Matthews SG 2003 Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinologica 28 87-102.
16. Chhajlani V, Muceniece R & Wikberg JE 1993 Molecular cloning of a novel human melanocortin receptor. Biochemical and Biophysical Research Communications 195 866-873.
17. 2 receptors in bovine fasciculata cells. Endocrine Research 21 183-187.
18. Djavidani B, Sander M, Kreutz R, Zeh K, Bader M, Mellon SH, Vecsei P, Peters J & Ganten D 1995 Chronic dexamethasone treatment suppresses hypertension development in the transgenic rat TGR(mREN2)27. Journal of Hypertension 13 637-645.
19. Gaillard RC, Grossman A, Gillies G, Rees LH & Besser GM 1981 Angiotensin II stimulates the release of ACTH from dispersed rat anterior pituitary cells. Clinical Endocrinology 15 573-578.
20. Gaillard RC, Favrod-Coune CA, Capponi AM & Muller AF 1985 Corticotropin-releasing activity of the renin-angiotensin system peptides in rat and in man. Neuroendocrinology 41 511-517.
21. Gasc JM, Shanmugam S, Sibony M & Corvol P 1994 Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 24 531-537.
22. Jezova D, Ochedalski T, Kiss A & Aguilera G 1998 Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. Journal of Neuroendocrinology 10 67-72.
23. 1B angiotensin II receptor messenger RNA in forebrain of 2-wk-old rats. American Journal of Physiology 271 E104-E112.
24. JöhrenO, Inagami T & Saavedra JM 1995 AT1A, AT1B, andAT2 angiotensin II receptor subtype gene expression in rat brain. Neuroreport 6 2549-2552.
25. Jöhren O, Neidert SJ, Kummer M, Dendorfer A & Dominiak P 2001 Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142 3324-3331.
26. 1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension 41 984-990.
27. Jöhren O, Dendorfer A, Dominiak P & Raasch W 2007 Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Brain Research 1184 160-167.
28. Lebrethon MC, Naville D, Begeot M & Saez JM 1994 Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. Journal of Clinical Investigation 93 1828-1833.
29. Leong DS, Terron JA, Falcon-Neri A, Armando I, Ito T, Jöhren O, Tonelli LH, Hoe KL & Saavedra JM 2002 Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT(1A), AT(1B) and AT(2) receptors. Neuroendocrinology 75 227-240.
30. Liakos P, Chambaz EM, Feige JJ & Defaye G 1998 Expression of ACTH receptors (MC2-R and MC5-R) in the glomerulosa and the fasciculata-reticularis zones of bovine adrenal cortex. Endocrine Research 24 427-432.
31. Llorens-Cortes C, Greenberg B, Huang H & Corvol P 1994 Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24 538-548.
32. McEwan PE, Vinson GP & Kenyon CJ 1999 Control of adrenal cell proliferation by AT1 receptors in response to angiotensin II and low-sodium diet. American Journal of Physiology 276 E303-E309.
33. Monti J, Schinke M, Bohm M, Ganten D, Bader M & Bricca G 2001 Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN). American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 280 R233-R240.
34. Müller H, Schweitzer N, Jöhren O, Dominiak P & Raasch W 2007 Angiotensin II stimulates the reactivity of the pituitary-adrenal-axis in leptin resistant Zucker rats thereby influencing the glucose utilization. American Journal of Physiology. Endocrinology and Metabolism 293 E802-E810.
35. Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous R & Saez JM 1993 Characterization and regulation of the angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata-reticularis cells. FEBS Letters 321 184-188.
36. Naville D, Bordet E, Berthelon MC, Durand P & Begeot M 2001 Activator protein-1 is necessary for angiotensin-II stimulation of human adreno-corticotropin receptor gene transcription. European Journal of Biochemistry 268 1802-1810.
37. Ogishima T, Suzuki H, Hata J, Mitani F & Ishimura Y 1992 Zone-specific expression of aldosterone synthase cytochrome P-450 and cytochrome P-45011 beta in rat adrenal cortex: histochemical basis for the functional zonation. Endocrinology 130 2971-2977.
38. Oliveira DR, Santos RA, Santos GF, Khosla M & Campagnole-Santos MJ 1996 Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension 27 1284-1290.
39. Paxinos G & Watson C 1998 The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press.
40. Penhoat A, Jaillard C & Saez JM 1994 Regulation of bovine adrenal cell corticotropin receptor mRNA levels by corticotropin (ACTH) and angiotensin-II (A-II). Molecular and Cellular Endocrinology 103 R7-10.
41. Penhoat A, Lebrethon MC, Begeot M & Saez JM 1995 Regulation of ACTH receptor mRNA and binding sites by ACTH and angiotensin II in cultured human and bovine adrenal fasciculata cells. Endocrine Research 21 157-168.
42. Raasch W, Dominiak P, Ziegler A & Dendorfer A 2004a Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation. Hypertension 44 346-351.
43. 1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. Journal of Hypertension 22 611-618.
44. Raasch W, Dominiak P & Dendorfer A 2005 Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy? Journal of Hypertension 23 1597-1604.
45. Raasch W, Wittmershaus C, Dendorfer A, Voges I, Pahlke F, Dodt C, Dominiak P & Jöhren O 2006 Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in SHR. Endocrinology 147 3539-3546.
46. Rivier C & ValeW1983 Effect of angiotensin II on ACTH release in vivo: role of corticotropin-releasing factor. Regulatory Peptides 7 253-258.
47. Sander M, Bader M, Djavidani B, Maser-Gluth C,Vecsei P, Mullins J,Ganten D & Peters J 1992 The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. Endocrinology 131 807-814.
48. Schelling P, Hutchinson JS, Ganten U, Sponer G & Ganten D 1976 Impermeability of the blood-cerebrospinal fluid barrier for angiotensin II in rats. Clinical Science & Molecular Medicine 3 399s-402s.
49. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D & BaderM 1999 Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. PNAS 96 3975-3980.
50. Schoenenberg P, Kehrer P, Muller AF & Gaillard RC 1987 Angiotensin II potentiates corticotropin-releasing activity of CRF41 in rat anterior pituitary cells: mechanism of action. Neuroendocrinology 45 86-90.
51. Seltzer A, Bregonzio C, Armando I, Baiardi G & Saavedra JM 2004 Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Research 1028 9-18.
52. Sumitomo T, Suda T, Nakano Y, Tozawa F, Yamada M & Demura H 1991 Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Endocrinology 128 2248-2252.
53. Tsalenko A, Sharan R, Kristensen V, Edvardsen H, Borresen-Dale AL, Ben Dor A & Yakhini Z 2006 Analysis of SNP-expression association matrices. Journal of Bioinformatics and Computational Biology 4 259-274.
54. Uresin Y, Erbas B & Ozek M 2004 Losartan may prevent the elevation of plasma glucose levels induced by chronic stress. Polish Journal of Pharmacology 56 271-273.
55. Wang H, Huang BS, Ganten D & Leenen FH 2004 Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circulation Research 94 843-849.
56. Zhang W, Huang BS & Leenen FH 1999 Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. American Journal of Physiology 276 H1608-H1615.